Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters)

Stefan Gluck, Jacques Bonneterre, Aman Buzdar, Jean Marc Nabholtz, John Robertson, Beat Thrlimann, Mikael Von Euler, Tarek Sahmoud, Mark Steinberg, Alan Webster

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)2442-2444
Number of pages3
JournalCancer
Volume95
Issue number11
DOIs
StatePublished - Dec 1 2002
Externally publishedYes

Fingerprint

Hormonal Antineoplastic Agents
Nitriles
Triazoles
Tamoxifen
Reproducibility of Results
Multicenter Studies
Disease Progression
Research Design
Retrospective Studies
Clinical Trials
Hormones
Breast Neoplasms
Therapeutics
anastrozole

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gluck, S., Bonneterre, J., Buzdar, A., Nabholtz, J. M., Robertson, J., Thrlimann, B., ... Webster, A. (2002). Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters). Cancer, 95(11), 2442-2444. https://doi.org/10.1002/cncr.10962

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters). / Gluck, Stefan; Bonneterre, Jacques; Buzdar, Aman; Nabholtz, Jean Marc; Robertson, John; Thrlimann, Beat; Von Euler, Mikael; Sahmoud, Tarek; Steinberg, Mark; Webster, Alan.

In: Cancer, Vol. 95, No. 11, 01.12.2002, p. 2442-2444.

Research output: Contribution to journalArticle

Gluck, S, Bonneterre, J, Buzdar, A, Nabholtz, JM, Robertson, J, Thrlimann, B, Von Euler, M, Sahmoud, T, Steinberg, M & Webster, A 2002, 'Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters)', Cancer, vol. 95, no. 11, pp. 2442-2444. https://doi.org/10.1002/cncr.10962
Gluck, Stefan ; Bonneterre, Jacques ; Buzdar, Aman ; Nabholtz, Jean Marc ; Robertson, John ; Thrlimann, Beat ; Von Euler, Mikael ; Sahmoud, Tarek ; Steinberg, Mark ; Webster, Alan. / Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters). In: Cancer. 2002 ; Vol. 95, No. 11. pp. 2442-2444.
@article{69bbad94a24043abbc9b43c6d725daf4,
title = "Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters)",
author = "Stefan Gluck and Jacques Bonneterre and Aman Buzdar and Nabholtz, {Jean Marc} and John Robertson and Beat Thrlimann and {Von Euler}, Mikael and Tarek Sahmoud and Mark Steinberg and Alan Webster",
year = "2002",
month = "12",
day = "1",
doi = "10.1002/cncr.10962",
language = "English",
volume = "95",
pages = "2442--2444",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma (multiple letters)

AU - Gluck, Stefan

AU - Bonneterre, Jacques

AU - Buzdar, Aman

AU - Nabholtz, Jean Marc

AU - Robertson, John

AU - Thrlimann, Beat

AU - Von Euler, Mikael

AU - Sahmoud, Tarek

AU - Steinberg, Mark

AU - Webster, Alan

PY - 2002/12/1

Y1 - 2002/12/1

UR - http://www.scopus.com/inward/record.url?scp=0036889747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036889747&partnerID=8YFLogxK

U2 - 10.1002/cncr.10962

DO - 10.1002/cncr.10962

M3 - Article

VL - 95

SP - 2442

EP - 2444

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11

ER -